Mark Eisner
Direktor/Vorstandsmitglied bei The Genentech Foundation
Vermögen: 163 115 $ am 30.04.2024
Aktive Positionen von Mark Eisner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The Genentech Foundation | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Mark Eisner
Ehemalige bekannte Positionen von Mark Eisner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FIBROGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.12.2020 | 08.09.2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.03.2010 | - |
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Ausbildung von Mark Eisner
| Stanford University | Undergraduate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
| UC Berkeley School of Public Health | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| 2 |
Operativ
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Börse
- Insiders
- Mark Eisner
- Erfahrung
